SCHEMBL6313847

SCHEMBL6313847

CCn1c2ccccc2c2cc(C(=O)C(=O)O)ccc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.62
MAPT P10636 5/20 0.62
ALDH1A1 P00352 4/20 0.62
LMNA P02545 3/20 0.62
HPGD P15428 2/20 0.62
MAPK1 P28482 2/20 0.57
POLB P06746 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
CNR2 P34972 1/20 0.55
KMT2A Q03164 4/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
MEN1 O00255 3/20 0.55
HTT P42858 1/20 0.55
HBB P68871 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.54
RORC P51449 2/20 0.54
RECQL P46063 1/20 0.54
NPY5R Q15761 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13640231 0.92 KDM4E (0.57) KDM4EMAPTALDH1A1LMNAHPGD
SCHEMBL2734561 0.88 ALDH1A1 (0.78) KDM4EMAPTALDH1A1LMNAHPGD
SCHEMBL10579016 0.86 KDM4E (0.67) KDM4EMAPTALDH1A1LMNAHPGD
SCHEMBL29528611 0.85 CNR2 (0.74) KDM4EMAPTALDH1A1LMNAHPGD
Formaldehyde SCHEMBL27586290 0.85 ALDH1A1 (0.74) KDM4EMAPTALDH1A1LMNAHPGD
SCHEMBL9457046 0.85 CNR2 (0.74) KDM4EMAPTALDH1A1LMNAHPGD
SCHEMBL30150496 0.85 KDM4E (0.68) KDM4EMAPTALDH1A1LMNAHPGD
SCHEMBL28190231 0.85 KDM4E (0.65) KDM4EMAPTALDH1A1LMNAHPGD
SCHEMBL5662028 0.85 HPGD (0.72) KDM4EMAPTALDH1A1LMNAHPGD
SCHEMBL7979578 0.85 KDM4E (0.68) KDM4EMAPTALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1244666-C Fluorescent maleimides and uses thereof CIBA SC HOLDING AG (CH) 2006-03-08 CN disclosed
CN-1721498-A Fluorescent maleimides and uses thereof CIBA SC HOLDING AG (CH) 2006-01-18 CN disclosed
US-6960667-B2 Fluorescent maleimides and uses thereof CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-11-01 US disclosed
US-20030189191-A1 Fluorescent maleimides and uses thereof KUNIMOTO KAZUHIKO (JP) 2003-10-09 US disclosed
US-6508957-B2 Ultraviolet fluorescent material for void detection and for preparation of scintillators, films, luminescent solar energy collectors, organic electroluminescent devices, printing inks, electrophotographic toners CIBA SPECIALTY CHEMICALS CORPORATION 2003-01-21 US disclosed
CN-1374995-A Fluorescent maleimides and uses thereof CIBA SC HOLDING AG (CH) 2002-10-16 CN disclosed
EP-1216285-A1 FLUORESCENT MALEIMIDES AND USES THEREOF Ciba SC Holding AG (CH) 2002-06-26 EP disclosed
US-20020065422-A1 Fluorescent maleimides and uses thereof KUNIMOTO KAZUHIKO (JP) 2002-05-30 US disclosed
US-6258954-B1 ELECTROLUMINESCENCE; DETECTION VOIDS CIBA SPECIALTY CHEMICALS CORP. 2001-07-10 US disclosed
WO-2001019939-A1 FLUORESCENT MALEIMIDES AND USES THEREOF CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065422-A1 Fluorescent maleimides and uses thereof IK, PAH, MYO1F KDM4E 1873/4885MAPT 1437/4885ALDH1A1 286/4885
US-20030189191-A1 Fluorescent maleimides and uses thereof CBR1, CBR3, MT-CO2 KDM4E 2373/4885MAPT 4621/4885ALDH1A1 701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.